In our in vitro experiments, we used three non-small cell lung cancer (NSCLC) cell lines to confirm that PLEK2 knockdown significantly inhibited tumor cell growth and migration (Fig. 7d-f). The gene discussed is PLEK2; the disease is non-small cell lung carcinoma.